Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
53,185,766
-
Total 13F shares
-
31,212,908
-
Share change
-
+31,212,908
-
Total reported value
-
$1,098,804,001
-
Price per share
-
$35.50
-
Number of holders
-
51
-
Value change
-
+$1,098,804,001
-
Number of buys
-
51
Institutional Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (PMVP) as of Q3 2020
As of 30 Sep 2020,
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 (PMVP) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,212,908 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, VIKING GLOBAL INVESTORS LP, BOXER CAPITAL, LLC, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, and BlackRock Inc..
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.